Histopathology confirmed tRCC based on morphology and immunohistochemistry despite a negative TFE3 split FISH (fluorescence in situ hybridization) result. This evidence concerns the gene TFE3 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.